Use of adrenaline in allergy

European Annals of Allergy and Clinical Immunology

Volumn 40, Issue 2, 2008, Pages 35-52

  Perino, A ^a   Galimberti, M ^a   Bilo M B ^a   Asero, R ^a   Pezzuto, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCAGON; HISTAMINE H1 RECEPTOR ANTAGONIST; HYPNOTIC AGENT; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; OXYTOCIN; PHENTOLAMINE; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLERGY; ANAPHYLAXIS; DRUG EFFICACY; DRUG INDICATION; HUMAN; INJECTION PAIN; RECOMMENDED DRUG DOSE; REVIEW; SELF INJECTION;

ADRENERGIC AGONISTS; ANAPHYLAXIS; EPINEPHRINE; HUMANS; SELF ADMINISTRATION;

EID: 49049106549     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics 2003; 111: 1601-8.
2. Simons FE. First-aid treatment of anaphylaxis to food:focus on epinephrine. J Allergy Clin Immunol 2004; 113: 837-44.
3. Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-50.
4. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reaction to food. J Allergy Clin Immunol 2001; 107: 191-3.
5. Simons FE, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002; 110: 647-51.
6. Johnston SL, Unsworth J, Compels MM. Adrenaline given outside the context of life threatening allergic reactions. BMJ 2003; 326: 589-90.
7. McLean-TookeAP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis:what is the evidence? BMJ 2003; 327: 1332-5.
8. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms.J Allergy Clin Immunol 2002; 110: 341-8.
9. Kemp SF, Deshazo RD. Prevention and treatment of anaphylaxis. Clin Allergy Immunol 2004; 18: 729-54.
10. Calvari M, Cardinale F, Martello A, Muraro A, Pucci N, Savino F. Indicazioni alla prescrizione e somministrazione dell'adrenalina nel bambino affetto da anafilassi. Riv Immunol Allergol Ped 2005; 3: 11-9.
11. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 2006; 117: 391-7.
12. Lieberman P, Kemp SF, OppenheimerJ, Lang DM, Bernstein L, Nicklas RA. The diagnosis and management of anaphylaxis: An updated practice parameter. J Allergy Clin Immunol 2005; 115: S483-523.
13. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114: 371-6.
14. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005; 5: 359-64.
15. Brown AF. Anaphylaxis gets the adrenaline going. Emerg Med J 2004; 21: 128-9.
16. Kemp SF, Lockey RF. Anaphylaxis: A review of causes and mechanisms. J Allergy Clin Immunol 2002; 110: 341-8.
17. Simons FE. Anaphylaxis, killer allergy: Long-term management in the community. J Allergy Clin Immunol 2006; 117: 367-77.
18. Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115: 584-91.
19. Tang AW. A practical guide to anaphylaxis. Am Fam Physicians 2003; 68: 1325-32.
20. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006; 97: 30-43.
21. Braganza SC, Acworth JP, Mackinnon DR, Peake JE, Brown AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91: 159-63.
22. Ellis AK, Day GH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation in 103 patients. Ann Allergy Asthma Immunol 2007; 98: 64-9.
23. Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000; 106: 762-6.
24. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005; 95: 211-2.
25. Simon GA, Brown MB. Clinical features and severity grading of anaphylaxis. Ann Allergy Clin Immunol 2004; 114: 371-6.
26. Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and treatment. Med J Austr 2006; 185: 283-9.
27. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmstead County: a population study. J Allergy Clin. Immunol 1999; 104: 452-6.
28. Boros CA, Kay D, Gold MS. Parent reported allergy and anaphylaxis in 4173 South Australian Children. J Paediatr Child Health 2000; 36: 36-40.
29. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States. An investigation into its epidemiology. Arch Intern Med 2001; 161: 15-21.
30. Clark S, Gaeta TJ, Kamarthi GS, Camargo CA. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol 2006; 16: 696-700.
31. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in United Kingdom. Arch Intern Med 2004; 164: 317-9.
32. Bohlke K, Davis RL, DeStefano F, et al. Epidemiology of anaphylaxis among children and adolescent enrolled in a health maintenance organization. J Allergy Clin Immunol 2004; 113: 536-42.
33. Moneret- Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening anaphylaxis: a review. Allergy 2005; 60: 443-51.
34. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285-90.
35. Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006; 97: 596-602.
36. Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Cromatogr B 2001; 756: 11-7.
37. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108: 861-6.
38. Simons FE, Chad ZH, Gold M. Anaphylaxis in children: real-time reporting from a national network. Allergy Clin Immunol Int J World Allergy Org 2004; (Suppl): 242-4.
39. Galimberti M, Maspoli M, Cadario G. La rete regionale di allergologia e l'Osservatorio per le gravi reazioni allelgiche. Not Allergologico 2002; 21: 206-9.
40. Maspoli M, Attisano C, Galimberti M. L'organizzazione in "Rete Regionale" dei servizi sanitari: l'esperienza della Regione Piemonte. Not Allergologico 2003; 22: 53-8.
41. Mullins RJ. Anaphylaxis: risk factor for recurrence. Clin Exp Allergy 2003; 23: 1033-40.
42. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004; 4: 285-90.
43. Sampson HA. Peanut allergy. N Engl J Med 2002; 346: 1294-9.
44. Florian S, Kraut MT, Simonitsch-Krupp I, et al. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005; 136: 273-80.
45. Laske N, Bunikowski R, Niggerman B. Extraordinarily high serum IgE and consequences for atopic phenotypes. Ann Allergy Asthma Immunol 2003; 91: 202-4.
46. Miller MM. Beta-blockers and anaphylaxis: are the risks overstated? J Allergy Clin Immunol 2005; 116: 933-4.
47. Cianferoni A, Novembre E, Pucci N, Lombardi E, Bernardini R, Vierucci A. Anaphylaxis: a 7-years follow-up survey of 46 children. Ann Allergy Asthma Immunol 2004; 92: 464-8.
48. Kemp A. Epipen epidemics. Reply. J Pediatr Child Health 2003; 40: 241-2
49. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Op Allergy Clin Immunol 2003; 3: 313-8.
50. Greenberger PA. Epinephrine for anaphylaxis. Ann Allergy Asthma Immunol 2005; 94: 515-6.
51. Anchor J, Settipane RA. Appropriate use of epinephrine in anaphylaxis. Am J Emerg Med 2004; 22: 488-90.
52. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108: 871-3.
53. Song TT, Nelson MR, Chang JH, Engler RJ, Chowdbury BA. Adequacy of epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 2005; 94: 539-42.
54. Simons FE, Gu X, Johnston L, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics 2000; 109: 720-3.
55. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta-2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials. Am J Emerg Med 2006; 24 (2): 217-22.
56. Portland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 2006; 47: 559-63.
57. Rawas-Qalaji MM, Simons FE. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 2006; 117: 398-403.
58. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004; 21: 149-15.
59. Lang DM. Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers. Drug Saf 1995; 12: 299-304.
60. Goddet NS, Deschata A, Liberge O, et al. Paradoxical reaction to epinephrine induced by beta-blockers in anaphylactic shock induced by penicillin. Eur J Emerg Med 2006; 13: 358-60.
61. Vander Zanden J, Valuck B, Brunch C, et al. Systemic adverse effects of ophthalmic beta-blockers. Ann Pharmacother 2001; 35: 1633-7.
62. Muller U, Haeberli G. Use of beta-blockers during immunotherapy for hymenoptera venom allergy. J Allergy Clin Immunol 2005; 115: 606-9.
63. Bonifazi F, Jutel M, Bilo' MB, Birnbaum J, Muller U & the EAACI Interest Group of Insect Venom Hypersensitivity. Prevention and Treatment of Hymenoptera Venom Allergy: Guidelines for clinical practice. Allergy 2005; 60: 1459-70.
64. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22: 272-3.
65. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112: 451-2.
66. Cabestrero D, Pèrez-Paredes C, Fernandez-Cid R, Arribas M. Bronchospasm and laryngeal stridor as an adverse effect of oxytocin treatment. Crit Care 2003; 7: 392-3.
67. Gei AF, Pacheco LD, Vanhook JW, Hankins GD. The use of continuous infusion of epinephrine for anaphylactic shock during labor. Obstet Gynecol 2004; 102: 1332-5.
68. Kemp A. Epipen use: good clinical practice. J Paediatr Child Health 2004; 40: 72-4.
69. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first- aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005; 115: 575-83.
70. Ellis MD, Day JH. The role of epinephrine in the treatment of anaphylaxis. Curr Allergy Asthma Rep 2003; 3: 4-11.
71. Unsworth DJ. Adrenaline syringes are vastly over prescribed. Arch Dis Child 2001; 84: 410-1.
72. Hayman GR, Bansal JA, Bansal AS. Knowledge about using autoinjectable adrenaline: review of patients' case notes and interviews with general practitioners. Brit Med J 2003; 327: 1328-30.
73. Branco Ferreira M., Rodriguez Alves R. Are general practitioners alert to anaphylaxis diagnosis and treatment? Eur Annals Allergy Clin Immunol 2006; 38: 83-6.
74. Simons FER, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr autoinjectors: Past their prime? J Allergy Clin Immunol 2000; 105: 1025-30.
75. Krugman SD, Chiaramonte DR, Matsui EC. Diagnosis and management of food-induced anaphylaxis: a national survey of pediatricians. Pediatrics 2006; 118: 554-60.
76. Johnson TL, Parker AL. Rates of retrieval of self-injectable epinephrine prescriptions: a descriptive report. Ann AllergyAsthma Immunol 2006; 97: 694-7.
77. Barbi E, Gerarduzzi T, Longo G, Ventura A. Fatal allergy as a possible consequence of long-term elimination diet. Allergy 2004; 59: 668-9.
78. Murphy R. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatrics 2006; 117: 1862-9.
79. McIntyre CL, Sheetz AH, Carrol CR, Young MC. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatrics 2005; 116: 1134-40.
80. Haymore BR, Carr WW, Frank WT. Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route. Allergy Asthma Proc 2005; 26: 361-5.
81. Hass DA. Management of medical emergencies in the dental office: Conditions in each country, the extent of treatment by the Dentist. Anesth Prog 2006; 53: 20-4.
82. Hayman GR, Bansal JA, Bansal AS. Knowledge about using autoinjectable adrenaline: review of patients' case notes and interviews with general practitioners. Brit Med J 2003; 327: 1328-30.
83. Kelso JM. A second dose of epinephrine for anaphylaxis: How often needed and how to carry. J Allergy Clin Immunol 2006; 117: 464-5.
84. Simons FE. Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis. Ann Allergy Asthma Immunol 2005; 94: 534-8.
85. Fitzarris P, Empson M, Ameratunga R, et al. Anaphylaxis management: the essential role of adrenaline (epinephrine) autoinjectors. Should PHARMAC fund them in New Zealand? NZ Med J 2006; 5: 119-21.
86. Ewan PW, Clark AT. Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice. Clin Exp Allergy 2005; 35: 751-6.
87. Velissariou I, Cottrell S, Berry K, Wilson B. Management of adrenaline (epinephrine) induced digital ischaemia in children after accidental injection from an EpiPen. Emerg Med J 2004; 21: 388.
88. Kim JS, Sinacore JM, Pongracic A. Parental use of EpiPen for children with food allergies. J Allergy Clin Immunol 2005; 116: 164-8.
89. Mandell D, Curtis R, Gold M, Hardie S. Anaphylaxis: how do you live with it? Health Soc Work 2005; 30: 325-35.
90. Avery NJ, King RM, Knight S, Hourihane JO. Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol 2003; 14: 378-82.
91. Rosen JP. Empowering patients with a history of anaphylaxis to use an epinephrine autoinjector without fear. Ann Allergy Asthma Immunol 2006; 97: 418.
92. Walker S, Sheick A. Managing anaphylaxis: effective emergency and long term care are necessary. Clin Exp Allergy 2003; 33: 1015-9.
93. Oude Elberink JN, van der Heide S, Guyatt GH, Dubois AE. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. J Allergy Clin Immunol 2006; 118: 699-704.
94. Hay GH, Harrer TB 3rd, Moore TG. Assessing the safety of severely food allergic children in school. J Sch Health 2006; 76: 479-81.
95. Patel MB, Bansaj PG, Tobin MC. Management of anaphylaxis in child care centers: evaluation 6 and 12 months after an intervention program. Ann Allergy Asthma Immunol 2006; 97: 813-5.
96. Murphy R. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatrics 2006; 117: 18629.
97. Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 857-71.
98. Bilò MB, Rueff F, Mosbech G, Bonifazi F, Oude-Elberink & EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339-49.
99. Bonifazi F, Bilò MB & AAITO Committee. Linee Guida AAITO sulla Diagnosi e Terapia della allergia a veleno di imenotteri. Eur Annals Allergy Clin Immunol 2004; S1: 1-24.
100. Moffit GE, Golden DBK, Reisman RE, et al. Stinging insect hypersensitivity: A Practice Parameter Update. J Allergy Clin Immunol 2004; 114: 869-86.
101. Asero R. Plant food allergies: diagnosis in clinical practice. Int ArchAllergy Immunol 2005; 138: 1-11.
102. Anadan C, Sheikh A. European developments in labelling allergenic foods. BMJ 2005; 331: 1156.
103. Perino A. in Allergia e Intolleranza Alimentare'; Capitolo 12, pag. 221-232. 2001 Pacini Editore.
104. Asero R, Mistrello G, Roncarolo D, e al. Immunological cross-reactivity between lipid transfer proteins from botanical unrelated plant-derived food: a clinical study. Allergy 2002; 57: 900-6.
105. Fiocchi A, Restani P, Ballabio C, et al. Severe anaphylaxis induced by latex as a contaminant of plastic balls in play pits. J Allergy Clin Immunol 2001; 108: 298-300.
106. Blanco C. Latex-fruit syndrome. Curr AllergyAsthma Rep 2003; 3: 47-53.
107. Beezhold DH, Reschke JE, Allen JH, Kostyal DA, Sussman GL. Latex protein: a hidden "food" allergen? Allergy Asthma Proc 2000; 21: 301-6.